We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

130 hedge funds and large institutions have $40.7M invested in Sanofi Contingent Value Rights in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 136 → 130 (-6)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

88% less capital invested

Capital invested by funds: $338M → $40.7M (-$297M)

Holders
130
Holders Change
-6
Holders Change %
-4.41%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
26
Increased
24
Reduced
32
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$11.4M
2
CPM
Chesapeake Partners Management
Maryland
+$5.44M
3
MCM
Mason Capital Management
New York
+$4.18M
4
PWAM
Park West Asset Management
California
+$3.63M
5
SI
Standard Investments
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
DI
Dalton Investments
Nevada
-$34M
2
SC
Sculptor Capital
New York
-$24.1M
3
ACM
Abrams Capital Management
Massachusetts
-$23.6M
4
AC
Aristeia Capital
Connecticut
-$13.2M
5
AAA
Alpine Associates Advisors
New Jersey
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$34K +$32.9K +27,262 +38%
KAM
52
Knightsbridge Asset Management
California
$26K -$50.9K -42,100 -36%
CCA
53
Catalyst Capital Advisors
New York
$26K -$6.04K -5,000 -6%
CAS
54
CTC Alternative Strategies
Illinois
$25.8K – – –
GCIA
55
Gabelli & Co Investment Advisers
New York
$24K -$991K -820,288 -92%
IRF
56
IBM Retirement Fund
New York
$24K – – –
ACA
57
Anchor Capital Advisors
Massachusetts
$21K -$230 -190 -0.3%
Korea Investment Corp
58
Korea Investment Corp
South Korea
$17K – – –
OCM
59
Osterweis Capital Management
California
$15K – – –
Morgan Stanley
60
Morgan Stanley
New York
$13K -$1.18M -978,733 -96%
Commonwealth Equity Services
61
Commonwealth Equity Services
Massachusetts
$13K +$26.7K +22,062 +147%
WHI
62
William Harris Investors
Illinois
$11K – – –
OC
63
Oppenheimer & Co
New York
$10K +$4.64K +3,838 +15%
RP
64
Reinhart Partners
Wisconsin
$7K – – –
SGH
65
Schonfeld Group Holdings
New York
$7K +$24.2K +20,000 New
BIA
66
Biondo Investment Advisors
Pennsylvania
$6K -$363 -300 -2%
PNC Financial Services Group
67
PNC Financial Services Group
Pennsylvania
$5K -$2.43K -2,010 -12%
PPA
68
Parametric Portfolio Associates
Washington
$5K -$1.04K -860 -5%
HK
69
Horizon Kinetics
New York
$5K – – –
ANI
70
American National Insurance
Texas
$5K +$19.5K +16,100 New
BlackRock
71
BlackRock
New York
$4K – – –
CGT
72
Capital Guardian Trust
California
$4K – – –
DA
73
Dillon & Associates
Michigan
$4K – – –
PHIMC
74
Private Harbour Investment Management & Counsel
Ohio
$4K – – –
Truist Financial
75
Truist Financial
North Carolina
$4K – – –
1 2
3
4 5

GCVRZ Hedge Fund Activity: Q4 2013 in Review

130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2013, worth a combined $40.7M — down 88% from $338M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of GCVRZ and 26 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $11.4M. The largest seller was Dalton Investments, exiting entirely with an estimated $34M sold.

  • 130 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2013, down from 136 in Q3 2013.
  • Funds reported $40.7M of Sanofi Contingent Value Rights stock for Q4 2013, down 88% quarter-over-quarter.
  • 26 funds opened new Sanofi Contingent Value Rights positions in Q4 2013 and 31 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2013 was Fir Tree Capital Management, an estimated $11.4M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2013 was Dalton Investments, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2013.